• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质母细胞瘤细胞的体外前列腺素E2生成及其对溶瘤淋巴细胞白细胞介素-2激活的影响。

In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

作者信息

Sawamura Y, Diserens A C, de Tribolet N

机构信息

Department of Neurosurgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

J Neurooncol. 1990 Oct;9(2):125-30. doi: 10.1007/BF02427832.

DOI:10.1007/BF02427832
PMID:2175768
Abstract

Glioblastoma cells constitutively produce various amounts of PGE2 (prostaglandin E2) in vitro. The amounts of PGE2 found in the conditioned medium of the glioblastoma cultures (less than 5 ng/ml) were not enough to inhibit the IL-2 (interleukin-2) activation of peripheral blood lymphocytes. However the amount of PGE2 produced by approximately 1 x 10(7) of the glioblastoma cells can be assumed to suppress the generation of IL-2-induced killing activity against glioblastoma cells.

摘要

胶质母细胞瘤细胞在体外持续产生不同量的前列腺素E2(PGE2)。在胶质母细胞瘤培养物的条件培养基中发现的PGE2量(小于5 ng/ml)不足以抑制外周血淋巴细胞的白细胞介素-2(IL-2)激活。然而,可以假定约1×10⁷个胶质母细胞瘤细胞产生的PGE2量能够抑制IL-2诱导的针对胶质母细胞瘤细胞的杀伤活性的产生。

相似文献

1
In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.胶质母细胞瘤细胞的体外前列腺素E2生成及其对溶瘤淋巴细胞白细胞介素-2激活的影响。
J Neurooncol. 1990 Oct;9(2):125-30. doi: 10.1007/BF02427832.
2
Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytes.前列腺素E2和环磷酸腺苷调节剂对白细胞介素-2激活的淋巴细胞杀伤人类胶质母细胞瘤细胞的影响。
J Neurosurg. 1990 Apr;72(4):619-25. doi: 10.3171/jns.1990.72.4.0619.
3
The augmentation of lymphokine-activated killer cell activity by indomethacin in vitro is not mediated by prostaglandin E2 suppression.吲哚美辛在体外增强淋巴因子激活的杀伤细胞活性并非由前列腺素E2抑制介导。
Proc Natl Sci Counc Repub China B. 1993 Oct;17(4):138-42.
4
Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine-activated killer cell function in patients with breast cancer.乳腺癌患者单核细胞中前列腺素E2生成增加,导致自然杀伤细胞和淋巴因子激活的杀伤细胞功能水平降低。
Cancer. 1993 Jul 15;72(2):491-501. doi: 10.1002/1097-0142(19930715)72:2<491::aid-cncr2820720227>3.0.co;2-1.
5
Prostaglandin E2 from macrophages of murine splenocyte cultures inhibits the generation of lymphokine-activated killer cell activity.来自小鼠脾细胞培养物中巨噬细胞的前列腺素E2可抑制淋巴因子激活的杀伤细胞活性的产生。
Tumour Biol. 1991;12(2):99-110. doi: 10.1159/000217694.
6
Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.小鼠纤维肉瘤细胞与各种抗肿瘤效应细胞共培养后体外前列腺素E2生成的增强
Br J Cancer. 1994 Aug;70(2):233-8. doi: 10.1038/bjc.1994.285.
7
Influence of immunotherapy (IL2 + LAK + inhibition of prostaglandin synthesis) on peripheral blood immune parameters and in vitro cytokine production in metastatic renal cell carcinoma.免疫疗法(白细胞介素2+淋巴因子激活的杀伤细胞+前列腺素合成抑制)对转移性肾细胞癌外周血免疫参数及体外细胞因子产生的影响
Urol Int. 1993;50(3):121-8. doi: 10.1159/000282469.
8
In vitro effects of prostaglandin E2 or indomethacin on the proliferation of lymphokine-activated killer cells and their cytotoxicity against bladder tumor cells in patients with bladder cancer.前列腺素E2或吲哚美辛对膀胱癌患者淋巴因子激活的杀伤细胞增殖及其对膀胱肿瘤细胞细胞毒性的体外作用。
Prostaglandins. 1997 Nov;54(5):769-79. doi: 10.1016/s0090-6980(97)00161-5.
9
Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages.前列腺素E2介导荷瘤宿主巨噬细胞对各种杀伤细胞系的失活作用。
J Leukoc Biol. 1988 Dec;44(6):474-84. doi: 10.1002/jlb.44.6.474.
10
Prostaglandin E2-mediated suppression of murine lymphokine-activated killer cell activity generated from tumor-bearing hosts by interferon-gamma.前列腺素E2介导的对由γ干扰素产生的荷瘤宿主来源的小鼠淋巴因子激活的杀伤细胞活性的抑制作用。
Mol Biother. 1990 Dec;2(4):228-32.

引用本文的文献

1
Dendritic cell therapy for neurospoagioma: Immunomodulation mediated by tumor vaccine.树突状细胞疗法治疗神经鞘瘤:肿瘤疫苗介导的免疫调节
Cell Death Discov. 2024 Jan 6;10(1):11. doi: 10.1038/s41420-023-01782-7.
2
The Promoting Effect of Traumatic Brain Injury on the Incidence and Progression of Glioma: A Review of Clinical and Experimental Research.创伤性脑损伤对胶质瘤发生发展的促进作用:临床与实验研究综述
J Inflamm Res. 2021 Aug 4;14:3707-3720. doi: 10.2147/JIR.S325678. eCollection 2021.
3
Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.

本文引用的文献

1
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.培养的星形胶质细胞和C6胶质瘤细胞产生前列腺素E和一种白细胞介素-1样因子。
J Immunol. 1982 Dec;129(6):2413-9.
2
Prostaglandin E inhibits the production of human interleukin 2.前列腺素E抑制人白细胞介素2的产生。
J Exp Med. 1982 Mar 1;155(3):943-8. doi: 10.1084/jem.155.3.943.
3
In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells.人外周血单个核细胞群体对前列腺素及相关脂质的体外合成
原发性中枢神经系统恶性肿瘤患者高剂量流感疫苗接种的免疫原性
Neurooncol Pract. 2018 Aug;5(3):176-183. doi: 10.1093/nop/npx035. Epub 2018 Jan 6.
4
Irradiation to Improve the Response to Immunotherapeutic Agents in Glioblastomas.放疗改善胶质母细胞瘤对免疫治疗药物的反应
Adv Radiat Oncol. 2018 Nov 20;4(2):268-282. doi: 10.1016/j.adro.2018.11.005. eCollection 2019 Apr-Jun.
5
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro.体外扩增的高纯度自然杀伤细胞联合替莫唑胺在体外诱导人胶质母细胞瘤细胞产生抗肿瘤作用。
PLoS One. 2019 Mar 6;14(3):e0212455. doi: 10.1371/journal.pone.0212455. eCollection 2019.
6
NK Cell-Based Glioblastoma Immunotherapy.基于自然杀伤细胞的胶质母细胞瘤免疫疗法。
Cancers (Basel). 2018 Dec 18;10(12):522. doi: 10.3390/cancers10120522.
7
The Pathophysiology of Post-Traumatic Glioma.创伤后胶质瘤的病理生理学。
Int J Mol Sci. 2018 Aug 19;19(8):2445. doi: 10.3390/ijms19082445.
8
Dendritic cell vaccines for high-grade gliomas.用于高级别胶质瘤的树突状细胞疫苗
Ther Clin Risk Manag. 2018 Jul 26;14:1299-1313. doi: 10.2147/TCRM.S135865. eCollection 2018.
9
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.通过对微阵列数据的生物信息学分析揭示胶质瘤和神经胶质瘤发病机制的分子机制。
Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
10
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?脑恶性肿瘤的免疫治疗:与其他部位有何不同?
Front Oncol. 2016 Dec 7;6:256. doi: 10.3389/fonc.2016.00256. eCollection 2016.
Prostaglandins. 1980 Jul;20(1):135-45. doi: 10.1016/0090-6980(80)90013-1.
4
Production of prostaglandins and thromboxane by isolated cells from intracranial tumours.颅内肿瘤分离细胞产生前列腺素和血栓素
J Neurol Neurosurg Psychiatry. 1984 Jun;47(6):579-84. doi: 10.1136/jnnp.47.6.579.
5
Regulation of the immune response by prostaglandins.前列腺素对免疫反应的调节
J Clin Immunol. 1983 Oct;3(4):295-315. doi: 10.1007/BF00915791.
6
Prostaglandin E2 as an immunomodulating factor released in vitro by human glioma cells.前列腺素E2作为人胶质瘤细胞在体外释放的一种免疫调节因子。
Acta Neuropathol. 1986;69(3-4):278-82. doi: 10.1007/BF00688305.
7
Local administration of autologous lymphokine-activated killer cells and recombinant interleukin 2 to patients with malignant brain tumors.对恶性脑肿瘤患者进行自体淋巴因子激活的杀伤细胞和重组白细胞介素2的局部给药。
Cancer Res. 1988 Sep 1;48(17):5011-6.
8
TGF-beta inhibits the in vitro induction of lymphokine-activated killing activity.转化生长因子-β抑制体外诱导的淋巴因子激活的杀伤活性。
Cancer Immunol Immunother. 1988;27(1):53-8. doi: 10.1007/BF00205758.
9
Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.重组白细胞介素-2透过血脑脊髓液屏障的情况。
J Neurosurg. 1988 Jul;69(1):29-34. doi: 10.3171/jns.1988.69.1.0029.
10
In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers.浸润人脑癌的T淋巴细胞的原位表征、克隆形成潜力及抗肿瘤细胞溶解活性
J Neurosurg. 1988 Mar;68(3):438-48. doi: 10.3171/jns.1988.68.3.0438.